1FW2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - WuXi Biologics (Cayman) Inc

Watchlist Manager

Watchlist

Price: 5.78 EUR -0.17%

Market Cap: €24B

	WuXi Biologics (Cayman) Inc F:1FW2	CN
R	Rheinmetall AG SWB:RHM	DE
	Starbucks Corp NASDAQ:SBUX	US
	Kao Corp F:KAO0	JP
H	HCA Healthcare Inc XMUN:2BH	US
	Banco Bilbao Vizcaya Argentaria SA NYSE:BBVA	ES
B	Bayan Resources Tbk PT XMUN:BNB	ID
I	Imperial Pacific Ltd ASX:IPC	AU
	Flap Kongre Toplanti Hizmetleri Otomotiv ve Turizm AS IST:FLAP.E	TR
	High Templar Tech Ltd NYSE:HTT	CN
M	ManpowerGroup Inc SWB:MPW	US
	Global Industrial Co F:GML0	US
I	Intercontinental Exchange Inc LSE:0JC3	US
	Advance Metals Ltd ASX:AVM	AU
	Stora Enso Oyj F:ENU	FI

Profitability Summary

WuXi Biologics (Cayman) Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

47%

Sustainable 3Y Average Gross Margin

43%

Gross Margin is Increasing

42% > 47%

Exceptional Operating Margin

31%

Sustainable 3Y Average Operating Margin

27%

Operating Margin is Increasing

26% > 31%

Healthy Net Margin

21%

Sustainable 3Y Average Net Margin

20%

Declining Net Margin

25% > 21%

Exceptional Free Cash Flow Margin

11%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Positive 3Y Average ROIC

10%

ROIC is Increasing

9% > 13%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.